Forma Therapeutics to Report Fourth Quarter and Year-end 2021 Financial Results and Provide Business Update on March 1, 2022
23 February 2022 - 11:05PM
Business Wire
Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a
clinical-stage biopharmaceutical company focused on sickle cell
disease, prostate cancer and other rare hematologic diseases and
cancers, today announced that it will release fourth quarter and
year-end 2021 financial results Tuesday, March 1, 2022. Forma
management will host an investment community conference call at 8
a.m. Eastern Standard Time (EST), on March 1, 2022 to discuss these
financial results and provide a business update.
Investors may participate by dialing (833) 301-1146 in the U.S.
or Canada, or (914) 987-7386 internationally, and by referring to
Conference ID 3322907. A live webcast of the conference call will
be available in the “News & Investors” section of Forma’s
website at www.formatherapeutics.com.
About Forma Therapeutics Forma Therapeutics is a
clinical-stage biopharmaceutical company focused on the research,
development and commercialization of novel therapeutics to
transform the lives of patients with rare hematologic diseases and
cancers. Our R&D engine combines deep biology insight,
chemistry expertise and clinical development capabilities to create
drug candidates with differentiated mechanisms of action focused on
indications with high unmet need. Our work has generated a broad
proprietary portfolio of programs with the potential to provide
profound patient benefit. For more information, please visit
www.FormaTherapeutics.com or follow us on Twitter @FORMAInc and
LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220223005333/en/
Investor Contact: Mario Corso, +1 781-366-5726 Forma
Therapeutics, Inc. mcorso@formatherapeutics.com
Forma Therapeutics (NASDAQ:FMTX)
Historical Stock Chart
From Jul 2024 to Aug 2024
Forma Therapeutics (NASDAQ:FMTX)
Historical Stock Chart
From Aug 2023 to Aug 2024
Real-Time news about Forma Therapeutics Holdings Inc (NASDAQ): 0 recent articles
More Forma Therapeutics Holdings Inc News Articles